Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: BJU Int. 2016 Mar 18;118(2):205–212. doi: 10.1111/bju.13444

Table 3.

a. Functional outcome, urinary continence
Various definitions of urinary continence reported by patients before surgery no. (%)
Pad-free and leakage free 247/290 (85.2)
Pad-free 287/290 (99.0)
Change of pad less than once per 24 hours 289/290 (99.7)
Urinary continence (Pad-free and leakage free) reported by patients 12 months after surgery no. (%)
Pad-free and leakage free 149/315 (47.3)
Pad-free and leakage free among pre-operatively pad-free and leakage-free patients 123/238 (51.7)
Pad-free and leakage free among preoperatively pad-free and leakage-free patients with bilateral nerve-sparing 95/178 (53.4)
Urinary continence (Pad-free) reported by patients 12 months after surgery no. (%)
Pad-free 226/315 (71.7)
Pad-free among preoperatively pad-free patients 199/276 (72.1)
Pad-free among preoperatively pad-free patients with bilateral nerve-sparing 154/205 (75.1)
Urinary continence (Change of pad less than once per 24 hours) reported by patients 12 months after surgery no. (%)
Change of pad less than once per 24 hours 264/315 (83.8)
# Change of pad less than once per 24 hours among patients with preoperatively change of pad less than once per 24 hours. 234/278 (84.2)
Change of pad less than once per 24 hours among patients with preoperatively change of pad less than once per 24 hours and bilateral nerve-sparing 181/206 (87.9)
b. Functional outcome, erectile function
Neurovascular bundle preservation no./total no. (%)
Bilateral, both sides interfascial or intrafascial dissection 242/337 (71.8)
Unilateral 54/337 (16.0)
None 41/337 (12.2)
Preoperative erectile function, reported by patients, different definitions no./total no. (%)
IIEF > 21 159/285 (55.8)
IIEF question 3 ≥ about half the time 233/287 (81.2)
Erectile function reported by patients 12 months after surgery no./total no. (%)
IIEF > 21 48/308 (15.6)
IIEF > 21 among patients with bilateral nerve-sparing 40/225 (17.8)
IIEF > 21 among patients that preoperatively had IIEF > 21 41/150 (27.3)
IIEF > 21 among patients that preoperatively had IIEF > 21 and with bilateral nerve-sparing 33/121 (27.3)
IIEF question 3 ≥ about half the time 115/312 (36.9)
IIEF question 3 ≥ about half the time among patients with bilateral nerve-sparing 96/227 (42.3)
# IIEF question 3 ≥ about half the time among patients that preoperatively had IIEF question 3 ≥ about half the time 98/222 (44.1)
IIEF question 3 ≥ about half the time among patients that preoperatively had IIEF question 3 ≥ about half the time and with bilateral nerve-sparing 82/172 (47.7)
c. Functional outcome, Trifecta
Potent and Continent at 12 months
Potent (IIEF question 3 ≥ about half the time) + continent (Change of pad less than once per 24 hours) among patient that preoperative was potent (≥ about half the time) + continent (Change of pad less than once per 24 hours)
no./total no. (%)
Yes 86/221 (38.9)
No 135/221 (61.1)
Trifecta at 12 months
BCR-free or no RT + potent (≥ about half the time) + continent (Change of pad less than once per 24 hours) among all patients
no./total no. (%)
Yes 101/312 (32.4)
No 211/312 (67.6)
Trifecta at 12 months
BCR-free or no RT + potent (≥ about half the time) + continent (Change of pad less than once per 24 hours) among preoperative potent and continent patients.
no./total no. (%)
Yes 84/221 (38.0)
No 137/221 (62.0)
#

The primary endpoint for urinary continence in the study.

#

The primary endpoint for erectile function in the study.